作者: PV Yermak , NF Gamaleia , AS Shalamay , TV Saienko , VV Kholin
DOI:
关键词:
摘要: Background: Application of hypericin (an alkaloid from Hypericum perforatum plants) as photodynamic agent may become the next successful step in therapy malignant tumors. Hyperflav — is a purified extract designed for purpose diagnosis. Aim: Present studies investigated effectiveness vitro application photosensitizer therapy. Methods: activity was assessed phototoxic cell tests on Jurkat, MT-4 and Namalwa leukemic lines. Spectroscopic measurements solutions were performed. Results: aqueous solubility maintained presence polyvinylpyrrolidone with most pronounced at 1:5 (w/w) Hyperflav-PVP ratio. fluorescence spectrum ethanol exhibits two main peaks around 597 647 nm, accordance pure hypericin. Fluorescence solution 604 655 nm indicates decreasing intensity. drug dose range 5 –25 μg/ml light 15 J/cm 2 showed dose-dependent cytotoxicity tested cultures, while dark not observed. Light irradiation samples preincubated resulted 69.9, 76.0 78.3% death respectively. Combined preparation gold nanoparticles low photocytotoxicity (24.2%) comparison alone (99.6%) cells. Conclusion: being solubilized nontoxic media doses that do have toxicity, therefore it meets requirements perspective photosensitizer.